• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Bridge To Nowhere

  • Thu, 2/16/12 - 10:43am
  • 793 reads
  • 0 comments

This is a case of a 52-year-old man who presented to our practice requesting paperwork be filled out for his disability claim. He had been diagnosed with PVD 2 years prior. He was found to have a totally occluded proximal right SFA about 10 mm distal to the profundus origin. He was referred for a femoropopliteal bypass surgery. One month after the surgery he had a recurrence of symptoms. He was unable to walk 50 feet without severe claudication. He was then told that nothing further could be done and his medical therapy was optimized with little effect. Eleven months later, he presented to Phoenix Heart Center for the above referenced paperwork. ABI’s were repeated and were documented to be 0.3 on the right leg and normal on the left leg. After much discussion and education, he was convinced that another angiogram with intent to intervene was reasonable prior to applying for disability.

A repeat angiogram was performed and this showed the same complete occlusion just below the origin of the profunda artery. There was reconstitution at the level of the adductor canal. Normal 3-vessel runoff was demonstrated. Using a contralateral approach, a 6 Fr Ansel sheath was advanced to the ostium of the right superficial femoral artery. We then advanced a Big-Boss catheter (BridgePoint Medical) over a Miracle Bro 3 (Asahi, Abbott Vascular) wire for back up. The Big-Boss catheter advanced from the true lumen through the totally occluded segment without much difficulty. When the catheter was nearing the distal cap we advanced the Miracle-Bro 3 wire through the cap into the popliteal artery. Angiography demonstrated that the wire was in the distal true lumen. Because the appearance of the proximal cap showed there was possible thrombus, we decided to proceed with a Pathway catheter. This catheter was advanced with the blades down initially and additional passes were made with the blades up. There was considerable resistance to passage in the mid-SFA. An angiogram showed some fibrous appearing plaque after the Pathway catheter was removed. PTA was performed with a 100 mm long balloon (AngioSculpt) the whole length of the SFA. This resulted in an excellent angiographic result with approximately a 20% residual lesion in the mid SFA. The patient is now enrolled in an exercise program and remains asymptomatic. Needless to say he withdrew his application for disability and has returned to work.

Perhaps we are all too willing to say that nothing can be done, and we dare not challenge difficult or seemingly impossible cases (not that this case was difficult or impossible). But if we do not try then we cannot state for certain that nothing can be done to fix the problem.

Figure 1. Pre proximal.

 

 

 

Figure 2. Pre distal.

 

 

 

Figure 3. BridgePoint.

 

 

 

Figure 4. Pathway.

 

 

 

Figure 5. Post Pathway.

 

 

 

Figure 6. AngioSculpt.

 

 

 

Figure 7. Post proximal.

 

 

 

Figure 8. Post distal.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to Open AAA Repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications